Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran-pyrazole derivatives as anticancer agents
- PMID: 26368040
- DOI: 10.1016/j.bioorg.2015.08.006
Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran-pyrazole derivatives as anticancer agents
Abstract
This study deals with design and synthesis of novel benzofuran-pyrazole hybrids as anticancer agents. Eight compounds were chosen by National Cancer Institute (NCI), USA to evaluate their in vitro antiproliferative activity at 10(-5)M in full NCI 60 cell panel. The preliminary screening of the tested compounds showed promising broad-spectrum anticancer activity. Compound 4c was further assayed for five dose molar ranges in full NCI 60 cell panel and exhibited remarkable growth inhibitory activity pattern against Leukemia CCRF-CEM, MOLT-4, Lung Cancer HOP-92, Colon Cancer HCC-2998, CNS Cancer SNB-75, Melanoma SK-MEL-2, Ovarian Cancer IGROV1, Renal Cancer 786-0, RXF 393, Breast Cancer HS 578T and T-47D (GI50: 1.00-2.71μM). Moreover, enzyme assays were carried out to investigate the possible antiproliferative mechanism of action of compound 4c. The results revealed that compound 4c has good c-Src inhibitory activity at 10μM. In addition, molecular docking studies showed that 4c could bind to the ATP Src pocket sites. Fulfilling the Lipinskiís rule of five in addition to its ADME profile and the biological results, all strongly suggest that 4c is a promising Src kinase inhibitor.
Keywords: Anticancer; Benzofuran; Molecular docking; Pyrazole.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.Anticancer Agents Med Chem. 2019;19(11):1368-1381. doi: 10.2174/1871520619666190417153350. Anticancer Agents Med Chem. 2019. PMID: 31038080
-
Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.Eur J Med Chem. 2015 Jan 27;90:620-32. doi: 10.1016/j.ejmech.2014.12.009. Epub 2014 Dec 6. Eur J Med Chem. 2015. PMID: 25499930
-
Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.Bioorg Chem. 2016 Dec;69:77-90. doi: 10.1016/j.bioorg.2016.10.001. Epub 2016 Oct 5. Bioorg Chem. 2016. PMID: 27744115
-
Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line.Bioorg Chem. 2020 Apr;97:103470. doi: 10.1016/j.bioorg.2019.103470. Epub 2019 Dec 14. Bioorg Chem. 2020. PMID: 32120072 Review.
-
Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds.Bioorg Med Chem. 2016 Aug 15;24(16):3521-6. doi: 10.1016/j.bmc.2016.05.061. Epub 2016 May 31. Bioorg Med Chem. 2016. PMID: 27288184 Review.
Cited by
-
Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies.J Enzyme Inhib Med Chem. 2021 Dec;36(1):270-285. doi: 10.1080/14756366.2020.1862101. J Enzyme Inhib Med Chem. 2021. PMID: 33327806 Free PMC article.
-
Development of a New Benzofuran-Pyrazole-Pyridine-Based Molecule for the Management of Osteoarthritis.Molecules. 2023 Sep 27;28(19):6814. doi: 10.3390/molecules28196814. Molecules. 2023. PMID: 37836657 Free PMC article.
-
New acetylenic derivatives of betulin and betulone, synthesis and cytotoxic activity.Med Chem Res. 2017;26(1):1-8. doi: 10.1007/s00044-016-1713-9. Epub 2016 Sep 1. Med Chem Res. 2017. PMID: 28111514 Free PMC article. Review.
-
Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects.Molecules. 2022 Jan 5;27(1):330. doi: 10.3390/molecules27010330. Molecules. 2022. PMID: 35011562 Free PMC article. Review.
-
Pyrazole Paradigms: Unveiling Synthetic Pathways and Unraveling Anti-Cancer Potential.Med Chem. 2024;20(8):799-817. doi: 10.2174/0115734064312273240429110026. Med Chem. 2024. PMID: 38757317 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
